These side effects were notably milder compared to an inhibitor of both bromodomains. An in depth molecular Investigation also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies offer paradigms for foreseeable future clinical trials in AML, and the usage https://lloydl665wht8.wikilinksnews.com/user